|
End-of-day quote
Moscow Micex - RTS
2022-07-08
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 114B 1.2B 1.12B 1.02B 1.93B 130B 1.95B 13.61B 5.27B 66.64B 5.09B 4.98B 214B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 175B 1.86B 1.74B 1.58B 2.98B 201B 3.01B 21B 8.14B 103B 7.86B 7.68B 330B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 2013-12-31 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dmitriy Genkin
CHM | Chairman | 57 | 2004-12-31 |
| Director/Board Member | 58 | - | |
Alexey Shafranov
BRD | Director/Board Member | 47 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +41.71% | 333B | |
| -1.46% | -2.89% | +10.57% | +32.81% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.98% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | +0.33% | -2.17% | +23.46% | +52.79% | 369.72B | |
| Weighted average by Cap. | -0.60% | -3.54% | +29.07% | +70.57% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 36.73B 389M 363M 331M 625M 42.14B 631M 4.4B 1.7B 21.54B 1.65B 1.61B 69.13B | 380M 31.82B 337M 315M 287M 541M 36.5B 546M 3.81B 1.48B 18.66B 1.43B 1.39B 59.88B |
| Net income | -698M -58.45B -620M -578M -527M -994M -67.06B -1B -7B -2.71B -34.28B -2.62B -2.56B -110B | -207M -17.39B -184M -172M -157M -296M -19.95B -299M -2.08B -807M -10.2B -779M -762M -32.73B |
| Net Debt | 693M 58.07B 616M 575M 524M 988M 66.61B 997M 6.95B 2.69B 34.05B 2.6B 2.55B 109B | 736M 61.7B 654M 611M 556M 1.05B 70.78B 1.06B 7.39B 2.86B 36.18B 2.76B 2.7B 116B |
Employees
59
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
